| 11590117 |
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide |
Soraya Carrancio, Paul Hollenbach, Antonia Lopez-Girona, Michael Pourdehnad, Irit Rappley +1 more |
2023-02-28 |
| 11241423 |
Antiproliferative compounds and methods of use thereof |
Brian E. Cathers, Joshua Hansen, Ehab M. Khalil, Antonia Lopez-Girona, Hon-Wah Man +3 more |
2022-02-08 |
| 10996215 |
Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers |
Matthew William Burnell Trotter, Patrick Hagner, Courtney G. Havens, Rajesh Chopra, Anita Gandhi +6 more |
2021-05-04 |
| 10695352 |
Combination therapy for treating malignancies |
Vivek Saroj Kumar Chopra, Jorge DiMartino, Laurie A. Kenvin, Robert Douglas Knight, Krishnan Viswanadhan +2 more |
2020-06-30 |
| 10653710 |
Combination therapy for treating malignancies |
Samuel V. Agresta, Krishnan Viswanadhan, Jorge DiMartino, Vivek Saroj Kumar Chopra, Robert Douglas Knight +2 more |
2020-05-19 |
| 10245258 |
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide |
Soraya Carrancio, Paul Hollenbach, Antonia Lopez-Girona, Michael Pourdehnad, Irit Rappley +1 more |
2019-04-02 |
| 9968596 |
Antiproliferative compounds and methods of use thereof |
Brian E. Cathers, Matthew D. Correa, Joshua Hansen, Antonia Lopez-Girona, Ehab M. Khalil +4 more |
2018-05-15 |
| 9808451 |
Antiproliferative compounds and methods of use thereof |
Brian E. Cathers, Matthew D. Correa, Joshua Hansen, Antonia Lopez-Girona, Ehab M. Khalil +4 more |
2017-11-07 |
| 9693987 |
Methods for treating cancers using oral formulations of cytidine analogs |
Aaron Nguyen, Jorge DiMartino |
2017-07-04 |
| 9499514 |
Antiproliferative compounds and methods of use thereof |
Joshua Hansen, Matthew D. Correa, Raj K. Raheja, Antonia Lopez-Girona, Hon-Wah Man +4 more |
2016-11-22 |
| 9125884 |
Methods for treating cancers using oral formulations of cytidine analogs |
Aaron Nguyen, Jorge DiMartino |
2015-09-08 |
| 9101579 |
Inhibition of drug resistant cancer cells |
Aaron Nguyen, Jorge DiMartino |
2015-08-11 |
| 8841277 |
Methods for treating non-small cell lung cancer using 5-azacytidine |
Aaron Nguyen |
2014-09-23 |
| 8492361 |
Methods for treating non-small cell lung cancer using 5-azacytidine |
Aaron Nguyen |
2013-07-23 |
| 7485308 |
26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
Rachel Meyers, Rory Curtis, Laura Rudolph-Owen, Nadine Weich, Peter Olandt +3 more |
2009-02-03 |
| 7301016 |
Human transferase family members and uses thereof |
Rachel Meyers, Mark Williamson, Kevin R. Leiby, Rosana Kapeller-Libermann, Peter Olandt +3 more |
2007-11-27 |
| 7235634 |
2786, a novel human aminopeptidase |
Rosana Kapeller-Libermann, David White |
2007-06-26 |
| 7098015 |
27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor |
Joseph Carroll, William James Cook, Rachel Meyers, Miyoung Chun, Mark Williamson |
2006-08-29 |
| 7071004 |
14094, a novel human trypsin family member and uses thereof |
Rachel Meyers |
2006-07-04 |
| 6872811 |
HRPCa9 and HRPCa10 nucleic acids and polypeptides |
Andrew W. Shyjan |
2005-03-29 |
| 6383780 |
2786, a novel human aminopeptidase |
Rosana Kapeller-Libermann, David White |
2002-05-07 |
| 6369210 |
22012, human carboxypeptidase |
Rosana Kapeller-Libermann, Mark Williamson |
2002-04-09 |
| 6322982 |
Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase |
Andrew W. Shyjan |
2001-11-27 |
| 6300092 |
Methods of use of a novel lysyl oxidase-related protein |
Mehran Khodadoust |
2001-10-09 |
| 5932422 |
Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase |
Andrew W. Shyjan |
1999-08-03 |